Secretary General Address Reinvigorated partnership with WHO
IUIS has long had an informal relationship with the World Health Organisation (WHO). In 2017, this relationship was formalized according to WHO guidelines. The goal of the collaboration is to advance WHO’s work on quality, safety and efficacy of medical biological products with IUIS providing relevant expert immunology knowledge. Our new relationship involves planned contributions from IUIS and its members.
Specifically, we will work together on the WHO Programme Area: access to medicines and health technologies and strengthening regulatory capacity. IUIS will provide support and knowledge in determining norms and standards for biologicals, especially vaccines, and scientific input on nomenclature of immunology molecules. We also support educational activities and communication to strengthen expertise in immunology.
We are grateful to Ivana Knezevic, who is our WHO liaison and has helped us immensely in creating this collaboration. We look forward to some exciting outcomes in the next three years!
IUIS is glad to introduce you its new committee: the IUIS Publications Committee(PUB). Its main goals are:
to establish and maintain a working relationship with Frontiers in Immunology as the official journal of IUIS
to develop policies for publishing and handling of data within the field of immunology
to promote IUIS communication, and
to support publications relating to IUIS meetings.
Lately, the Publication Committee finalized a new contractual relationship with Frontiers in Immunology. A highlight of the new relationship is the IUIS-sponsored Research Topics. To know more about the new oportunities for IUIS members, check the PUB webpage. We look forward to new submissions from members.
Our objective: promote and foster a younger generation of scientists in the early stages of their career!
The scope of the prize relates is to reward significant achievements in Vaccine R&D, including the discovery of new vaccine antigens, new vaccines design, understanding the basics of the immune response, new technologies that will improve the future of vaccines and vaccination and that are supported by proof-of-concept data (preclinical and clinical).
The 6th EWIV will take place in September 5-7 2018 in Utrecht, The Netherlands. Plenary and concurrent sessions will cover topics as varied as innate and adaptive immunology, vaccination, infection and immunity, clinical immunology, allergy, mucosal immunology and the microbiome in relation to immune responses.
IUIS 2019 Invited Speaker Nominations!
In late October, the IUIS 2019 Steering Committee will meet in Tianjin on occasion of the Chinese Society for Immunology's annual meeting to finalize the Scientific Program Committee.
All IUIS National Member Societies and Regional Federations will be asked to submit their speaker nominations by the end of the year. Stay tuned!
The IUIS-Brazil Advanced Course of Vaccines is an immersion course on advanced topics and current research on multiple aspects of vaccine development, including discovery, preclinical development, upscaling, manufacturing, clinical trials, and regulatory issues, with world-class specialists. Only a limited number of places is available.
IUIS Course Material - Providing online immunology education
Immunopaedia.orgis the official educational provider of online pre-course material for IUIS immunology courses in the developing world and in other countries. Supported and working closely with the IUIS Education Committee, Immunopaedia delivers relevant and current educational content to provide frameworks of knowledge to IUIS course participants before they embark on face-to-face courses.